The global sickle cell disease treatment market was valued at USD 2 billion in 2022 and grew at a CAGR of 20% from 2023 to 2032. The market is expected to reach USD 12.38 billion by 2032. The increasing prevalence of sickle cell disease will drive the growth of the global sickle cell disease treatment market.
Sickle cell disease (SCD) is a genetic disorder characterized by abnormal haemoglobin in red blood cells. This condition is inherited when an individual receives a mutated gene from both parents. The mutated gene leads to the production of misshapen red blood cells that can cause various health complications. Symptoms of sickle cell disease include anaemia, fatigue, and swelling of hands and feet. It also increases susceptibility to infections and delayed growth in children. Blood tests, genetic testing, and newborn screening are used for diagnosis. While there is no cure for sickle cell disease, several treatments aim to alleviate symptoms and improve the quality of life for individuals with the condition. Blood transfusions can help increase the number of normal red blood cells. A bone marrow transplant is also considered for severe cases.
Get an overview of this study by requesting a free sample
The increasing awareness about sickle cell diseases – the increasing awareness and accessibility to healthcare services that improve the chances of early-stage diagnosis have contributed to the increasing number of recorded sickle cell disease patients. Newborn screening, genetic counselling, and other awareness programmes have contributed to an official rise in the number of sickle cell disease patients. Newborn screening allows for early detection and intervention. Genetic counselling empowers individuals to make informed family planning decisions, reducing the likelihood of passing on the disease. Increased awareness, facilitated by educational programs, leads to early recognition and pre-emptive medical care for patients. Therefore, increasing awareness about sickle cell disease will lead to individuals seeking treatments and contribute to the global market's growth and development.
The side-effects of sickle cell disease treatment – medication side effects such as hair loss and gastrointestinal problems can hamper the market’s growth. Certain treatments heighten the susceptibility to infections. Bone marrow transplants present challenges involving complex procedures and difficulty finding suitable donors. These challenges reduce the quality of life for individuals, and therefore, many do not seek such treatments. Therefore, the potential side effects of treatments may limit the market's growth. Furthermore, the lack of awareness about treatment options or access to these treatments may hamper the market's growth.
Increasing research and innovation – Ongoing research focuses on identifying novel therapies, optimizing existing treatments, and exploring cutting-edge approaches like gene therapy and gene editing. These efforts by the scientific community aim to develop more effective and curative options. Additionally, the pursuit of customized or personalized medicine has the potential to offer tailored treatment plans with enhanced efficacy. Global collaboration is improving the understanding of SCD variations and treatment responses. All these advances in medicine will offer lucrative opportunities for the market players in the future.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global sickle cell disease treatment market, with a 37% market revenue share in 2022.
North America has advanced healthcare infrastructure, a robust research and innovation landscape, and specialized expertise with a diverse pool of scientists that drive innovation. Patient advocacy efforts and widespread health insurance coverage enhance awareness, early diagnosis, and improved access to healthcare services. Government support for research and innovation further propels advancements in SCD treatment.
North America Region Sickle Cell Disease Treatment Market Share in 2022 - 37%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The treatment type segment is divided into blood transfusion, pharmacotherapy, and bone marrow transplant. The blood transfusion segment dominated the market, with a market share of around 40% in 2022. Blood transfusion involves infusing donor blood or components into a recipient with SCD. Transfusions aim to temporarily increase normal red blood cells, improving oxygen delivery and reducing complications associated with sickle-shaped cells. This process is effective in managing specific SCD complications, including preventing stroke, alleviating severe anaemia, and reducing the risk of pain crises. Transfusions are a well-established treatment option and the most preferred one.
The end-user segment is divided into hospitals, speciality clinics, and others. The hospital segment dominated, with a market share of around 47% in 2022. Hospitals are comprehensive healthcare institutions, and they offer multidisciplinary care. They can access advanced diagnostics, which offers accurate assessments and prompt treatment planning. They offer Emergency care, ensuring swift interventions and improved patient outcomes. These institutions offer specialized units, blood transfusions, and various therapies crucial for SCD management. Hospitals also serve as hubs for research and clinical trials, providing opportunities for patients to access cutting-edge treatments. They can handle complex medical scenarios, making them optimal settings for SCD treatment.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2022 | USD 2 Billion |
Market size value in 2032 | USD 12.38 Billion |
CAGR (2023 to 2032) | 20% |
Historical data | 2019-2021 |
Base Year | 2022 |
Forecast | 2023-2032 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East and Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Treatment Type and End User |
As per The Brainy Insights, the size of the global sickle cell disease treatment market was valued at USD 2 billion in 2022 to USD 12.38 billion by 2032.
Global sickle cell disease treatment market is growing at a CAGR of 20% during the forecast period 2023-2032.
The market's growth will be influenced by the increasing awareness about sickle cell diseases.
The side-effects of sickle cell disease treatment could hamper the market growth.
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global sickle cell disease treatment market based on below mentioned segments:
Global Sickle Cell Disease Treatment Market by Treatment Type:
Global Sickle Cell Disease Treatment Market by End User:
Global Sickle Cell Disease Treatment Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date